Código QR (código de barras bidimensional)

Osimertinib as Salvage Therapy in Advanced Non‐Small Cell Lung Cancer After Aumolertinib Resistance With T790M Mutation: A Case Report

ABSTRACT The third generation of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is recommended universally as the standard treatment for non‐small cell lung cancer (NSCLC) carrying the EGFR T790M mutation. With the approval of multiple third‐generation EGFR‐TKIs, questions...

Fuld beskrivelse

Na minha lista:
Principais autores: Yongtong Tang, Jilan Xu, Qingle Chen, Jianping Lu, Li Ren, Taihe Lan, Taihua Liao, Xiaoling Chen, Hui Yi, Jun Zhang, Jie Huang
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2025-02-01
Serier:Clinical Case Reports
Fag:
aumolertinib
epithelial growth factor receptor
osimertinib
resistance
Online adgang:https://doi.org/10.1002/ccr3.70219
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker